HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Concurrent use of indomethacin and dexamethasone increases the risk of spontaneous intestinal perforation in very low birth weight neonates.

AbstractBACKGROUND:
Dexamethasone or indomethacin predisposes very low birth weight (VLBW) neonates to spontaneous intestinal perforation (SIP). However, no study has specifically investigated the role of the concurrent use of indomethacin and dexamethasone in SIP.
OBJECTIVE:
To test whether the concurrent use of indomethacin and dexamethasone increases the risk of SIP.
METHODS:
In this single center, retrospective, 2:1 matched, case-control study, the odds of SIP were assessed using univariate and multivariate logistic regression analysis in < or =14-day old VLBW infants.
RESULTS:
Sixteen VLBW infants with SIP were matched to 32 controls by birth weight. After adjusting for clinically relevant variables, patients who received > or =3 doses of indomethacin for ductal closure or intraventricular hemorrhage prophylaxis and > or =3 doses of low-dose dexamethasone (0.3 mg/kg cumulative dose over 3 days) for refractory hypotension during the first postnatal week, were 9.6 times more likely to develop SIP [95% CI 1.22, 75.71].
CONCLUSIONS:
The combined use of indomethacin and dexamethasone increases the risk of SIP in VLBW neonates.
AuthorsL Paquette, P Friedlich, R Ramanathan, I Seri
JournalJournal of perinatology : official journal of the California Perinatal Association (J Perinatol) Vol. 26 Issue 8 Pg. 486-92 (Aug 2006) ISSN: 0743-8346 [Print] United States
PMID16791261 (Publication Type: Journal Article)
Chemical References
  • Dexamethasone
  • Indomethacin
Topics
  • Case-Control Studies
  • Dexamethasone (administration & dosage, adverse effects)
  • Ductus Arteriosus, Patent (drug therapy)
  • Female
  • Humans
  • Hypotension (drug therapy)
  • Indomethacin (administration & dosage, adverse effects)
  • Infant, Newborn
  • Infant, Premature
  • Infant, Premature, Diseases (chemically induced, drug therapy)
  • Infant, Very Low Birth Weight
  • Intestinal Perforation (chemically induced)
  • Male
  • Risk Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: